Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia
Authors:
- Suwanna ChaorattanakaweeSCSuwanna Chaorattanakawee
- Stuart D TynerSTStuart D Tyner
- Chanthap LonCLChanthap Lon
- Kritsanai YingyuenKYKritsanai Yingyuen
- Wiriya RuttvisutinuntWRWiriya Ruttvisutinunt
- Siratchana SundrakesSSSiratchana Sundrakes
- Piyaporn Sai-GnamPSPiyaporn Sai-Gnam
- Jacob D JohnsonJJJacob D Johnson
- Douglas S WalshDWDouglas S Walsh
- David L SaundersDSDavid L Saunders
- Charlotte A LanteriCLCharlotte A Lanteri
Open Access
- 12 July 2013
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 239
Abstract
Background: Performance of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR Green I fluorescence (MSF) drug sensitivity tests were directly compared using Plasmodium falciparum reference strains and fresh ex vivo isolates from Cambodia against a panel of standard anti-malarials. The objective was to determine which of these two common assays is more appropriate for studying drug susceptibility of “immediate ex vivo” (IEV) isolates, analysed without culture adaption, in a region of relatively low malaria transmission. Methods: Using the HRP-2 and MSF methods, the 50% inhibitory concentration (IC50) values against a panel of malaria drugs were determined for P. falciparum reference clones (W2, D6, 3D7 and K1) and 41 IEV clinical isolates from an area of multidrug resistance in Cambodia. Comparison of the IC50 values from the two methods was made using Wilcoxon matched pair tests and Pearson’s correlation. The lower limit of parasitaemia detection for both methods was determined for reference clones and IEV isolates. Since human white blood cell (WBC) DNA in clinical samples is known to reduce MSF assay sensitivity, SYBR Green I fluorescence linearity of P. falciparum samples spiked with WBCs was evaluated to assess the relative degree to which MSF sensitivity is reduced in clinical samples. Results: IC50 values correlated well between the HRP-2 and MSF methods when testing either P. falciparum reference clones or IEV isolates against 4-aminoquinolines (chloroquine, piperaquine and quinine) and the quinoline methanol mefloquine (Pearson r = 0.85-0.99 for reference clones and 0.56-0.84 for IEV isolates), whereas a weaker IC50 value correlation between methods was noted when testing artemisinins against reference clones and lack of correlation when testing IEV isolates. The HRP-2 ELISA produced a higher overall success rate (90% for producing IC50 best-fit sigmoidal curves), relative to only a 40% success rate for the MSF assay, when evaluating ex vivo Cambodian isolates. Reduced sensitivity of the MSF assay is likely due to an interference of WBCs in clinical samples. Conclusions: For clinical samples not depleted of WBCs, HRP-2 ELISA is superior to the MSF assay at evaluating fresh P. falciparum field isolates with low parasitaemia (<0.2%) generally observed in Southeast Asia.Keywords
This publication has 34 references indexed in Scilit:
- Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolatesMalaria Journal, 2012
- Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assayMalaria Journal, 2012
- Differential Association of Plasmodium falciparum Na + /H + Exchanger Polymorphism and Quinine Responses in Field- and Culture-Adapted Isolates of Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2011
- Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumCurrent Opinion in Infectious Diseases, 2011
- Reliability of Antimalarial Sensitivity Tests Depends on Drug Mechanisms of ActionJournal of Clinical Microbiology, 2010
- Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytesMalaria Journal, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug ScreeningAntimicrobial Agents and Chemotherapy, 2007
- Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Human Malaria Parasites in Continuous CultureScience, 1976